Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/10/2010 | EP2248822A2 Meningococcus adhesins |
11/10/2010 | EP2247745A1 Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
11/10/2010 | EP2247744A1 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
11/10/2010 | EP2247743A2 Modified leptin polypeptides and their uses |
11/10/2010 | EP2247737A2 Fermentation medias and processes thereof |
11/10/2010 | EP2247609A1 Method for increasing expression yield of a protein of interest |
11/10/2010 | EP2247304A2 Her2/neu-specific antibodies and methods of using same |
11/10/2010 | EP1531836B1 Polypeptide cleavage process |
11/10/2010 | EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof |
11/10/2010 | EP1265915B1 Novel compounds |
11/10/2010 | EP1015477B1 32 Human secreted proteins |
11/10/2010 | EP0958362B1 Isolation and use of motoneuronotrophic factors |
11/10/2010 | CN101883862A Method for production of antibody |
11/10/2010 | CN101881770A Method for preparing porcine circovirus type 2 colloidal gold antibody fast test strip |
11/10/2010 | CN101880704A Method for preparing peptide albumen by utilizing fermentation of microalgae grease bacterial dregs and bacterial mud and application |
11/10/2010 | CN101880703A Method for fermenting daptomycin by adding caprate |
11/10/2010 | CN101880702A Method for producing glutathione through Candida utilis fermentation |
11/10/2010 | CN101880701A New method for preparing aprotinin derivatives by using methanol yeast |
11/10/2010 | CN101880685A Protein preparation method capable of improving immune effect on hepatitis B virus X protein |
11/10/2010 | CN101880675A High-level expression of tetanus toxin receptor binding domain Hc in Escherichia coli and application |
11/10/2010 | CN101880652A Recombinant Newcastle disease attenuated vaccine strain for expressing pig interferon (alpha, beta or gamma |
11/10/2010 | CN101880318A Virus protein granules of hepatitis E virus-4 ORF2 fragment and prepration method and application thereof |
11/10/2010 | CN101319011B Multi-type HCV-E1 epitope complex immunogen, encoding gene and application thereof |
11/10/2010 | CN101104637B Cecropin and its generation bacterial strain and use |
11/09/2010 | US7829687 comprising an N-terminal domain derived from E. coli FkpA that allows for dimerization and provides a substrate binding region, and a C-terminal thioredoxin domain derived from E. coli DsbA |
11/09/2010 | US7829682 human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP; for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP |
11/09/2010 | US7829681 Producing target polypeptide via protease digestion under increased hydrostatic pressure; autocatalytic protein fusions |
11/09/2010 | US7829678 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits |
11/09/2010 | US7829676 Whitefly ecdysone receptor antibody |
11/09/2010 | US7829675 TWEAK receptor |
11/09/2010 | US7829674 Compositions and methods for binding sphingosine-1-phosphate |
11/09/2010 | US7829673 comprises a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO:7 or encoded by the nucleotide sequence set forth in SEQ ID NO:6; inhibiting growth and/or proliferation of a cell expressing CD38; kits |
11/09/2010 | US7829672 Modulation of sodium channels in dorsal root ganglia |
11/09/2010 | US7829531 monoclonal antibody conjugated with peptide drug such as dolastatin derivative |
11/09/2010 | US7829526 DNA encoding peptide, an antibody against the peptide; cardioinhibitory, hypotensive agent; peptide as an active ingredient; marker protein, peptide tag |
11/09/2010 | US7829321 Method for the production of bacterial toxins |
11/09/2010 | US7829319 autoprotease Npro of Pestivirus, which have a lower pi and enhanced solubility are suitable for use in a wider range of conditions; production of heterologous polypeptides of interest with homogenous N-termini |
11/09/2010 | US7829311 Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate |
11/09/2010 | US7829310 Compositions of aminoacyl-tRNA synthetase and uses thereof |
11/09/2010 | US7829309 Cell culture performance with betaine |
11/09/2010 | US7829308 Neurogenin |
11/09/2010 | US7829307 Multimeric protein with linker having sequence ProValSerGlyProArg; [Gly2]hGLP-2 is produced from a multimeric precursor; genetic engineering and expression; biodrugs |
11/09/2010 | US7829306 Protein highly producing recombinant animal cell, method for preparing the same, and method for mass-producing protein using the same |
11/09/2010 | US7829294 antibody against a soluble fibrin, which does not react with fibrinogen but specifically recognizes a conformation-changed site newly occurred in a C-terminal region of an A alpha -chain of the soluble fibrin formed through thrombin digestion of fibrinogen; disseminated intravascular coagulation |
11/09/2010 | US7829290 Method and device for protein delivery into cells |
11/09/2010 | US7829103 immunogenic composition consisting of, as an active principle, a pure methylated heparin-binding hemagglutinin (HBHA) protein in a pharmaceutically acceptable formulation, and one or more adjuvants |
11/09/2010 | US7829095 Produced by hybridoma cell line DSM ACC 2533 |
11/09/2010 | US7829092 Recombinant anti-VLA4 antibody molecules |
11/09/2010 | US7829088 Composition comprising humanized antibody HBBK4 for the treatment of cancer and the use thereof |
11/09/2010 | US7829083 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2 |
11/09/2010 | US7829081 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
11/09/2010 | US7829078 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery; increasing the hematocrit and/or the reticulocyte count in a mammalian subject |
11/09/2010 | US7829075 Method for expanding hematopoietic cells using cytokine zalpha11 ligand |
11/09/2010 | CA2578137C Production of .alpha.-abeta |
11/09/2010 | CA2343102C Antisense modulation of survivin expression |
11/09/2010 | CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
11/09/2010 | CA2161684C Bioactive and/or targeted dendrimer conjugates |
11/04/2010 | WO2010127294A2 Dual variable domain immunoglobulins and uses thereof |
11/04/2010 | WO2010127284A2 Dual variable domain immunoglobulins and uses thereof |
11/04/2010 | WO2010127181A1 Improved antibodies immunoreactive with heregulin-coupled her3 |
11/04/2010 | WO2010127113A2 Toll-like receptor 3 antagonists |
11/04/2010 | WO2010126139A1 Protein-type electron mediator |
11/04/2010 | WO2010126073A1 Expression cassette for secretion/expression of polypeptide, and use thereof |
11/04/2010 | WO2010126066A1 Anti-il-3rα antibody for use in treatment of blood tumor |
11/04/2010 | WO2010105097A3 Sparc angiogenic domain and methods of use |
11/04/2010 | WO2010100595A9 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
11/04/2010 | WO2010040496A3 Location-specific recombination for activating genes in genetic systems |
11/04/2010 | WO2010017196A3 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
11/04/2010 | US20100281582 Polypeptides having xylanase activity and polynucleotides encoding same |
11/04/2010 | US20100281551 Modified transposon vector and its use |
11/04/2010 | US20100281549 Transgenic Production In Saliva |
11/04/2010 | US20100279942 Methods for treating motor neuron disease |
11/04/2010 | US20100279923 Therapeutic application of kazal-type serine protease inhibitors |
11/04/2010 | US20100279877 Method for Detection of Melanoma |
11/04/2010 | US20100279406 Alteration of tumor growth using zinc finger proteins |
11/04/2010 | US20100279365 Novel aldolase and production process of substituted alpha-keto acids |
11/04/2010 | US20100279354 Adapting microorganisms for agricultural products |
11/04/2010 | US20100279353 Process of producing fibrinolytic enzyme from mushroom |
11/04/2010 | US20100279352 Rapid Generation of Antibodies |
11/04/2010 | US20100279351 Method for Generation of Antibodies |
11/04/2010 | US20100279350 C-type lectin polypeptide, polynucleotide and methods of making and use thereof |
11/04/2010 | US20100279349 Nucleic acids encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor |
11/04/2010 | US20100279348 Yeast strains for protein production |
11/04/2010 | US20100279347 Polymyxin synthetase and gene cluster thereof |
11/04/2010 | US20100279346 Compositions and Methods for Improved Protein Production |
11/04/2010 | US20100279345 Aut0-inducible sodium phosphate symporter promoter from pichia pastoris and method for producing recombinant protein using it |
11/04/2010 | US20100279344 Integrated cytokine production system |
11/04/2010 | US20100279343 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
11/04/2010 | US20100279334 Cyclodipeptide synthases (cdss) and their use in the synthesis of linear dipeptides |
11/04/2010 | US20100279333 Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid |
11/04/2010 | US20100279331 Novel Transporter Protein in Mammal and Utilization of the Same |
11/04/2010 | US20100279313 Novel secreted immunomodulatory proteins and uses thereof |
11/04/2010 | US20100278875 Prostaglandin e2 (pge2) as an adjuvant in monoclonal antibody generation |
11/04/2010 | US20100278842 Anti-ephb2 antibodies and methods using same |
11/04/2010 | US20100278838 Epha2 monoclonal antibodies and methods of use thereof |
11/04/2010 | US20100278832 Anti-bst2 antibody |
11/04/2010 | US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth |
11/04/2010 | US20100278827 Concatameric immunoadhesion molecule |
11/04/2010 | US20100278820 Reagents that bind ccx-ckr2 |
11/04/2010 | US20100278818 Antibody specific for the Tn antigen for the treatment of cancer |